Literature DB >> 21143539

Stratum corneum removal facilitates experimental sensitization to mite allergens in atopic dogs.

Thierry Olivry1, Jessica Wofford, Judy S Paps, Stanley M Dunston.   

Abstract

In humans with atopic dermatitis and in mouse models of IgE-mediated allergic diseases, evidence is mounting that the stratum corneum (SC) provides an important barrier against environmental allergens. At this time, it is not known whether the SC has a similar role in dogs, especially in those with atopic dermatitis. The objectives of this pilot study were to determine whether SC removal led to earlier and stronger sensitization of atopic dogs to Dermatophagoides farinae (Df) house dust mites. Five Maltese-beagle atopic (MBA) dogs were sensitized epicutaneously after the SC was removed with ten tape strips (TS group), while sensitization was done without tape strips in five other MBA dogs (nontape stripping; NTS group). During this 16 week study, sensitization was assessed with allergen-specific IgE serology, intradermal testing with Df allergens and determination of stimulation indices of blood mononuclear cells cultured with Df and stained for CD4 and the activation markers CD25 or CD30. Compared with dogs from the NTS group, those of the TS group exhibited earlier rises in Df-specific IgE serum levels, usually had higher allergen-specific IgE titres, showed higher intradermal test reactivity and had earlier increases and higher percentages of CD25- or CD30-positive activated allergen-specific peripheral CD4-positive T lymphocytes. These observations implicate a role of the SC as a barrier limiting sensitization to exogenous allergens in this experimental atopic dog model.
© 2010 The Authors. Journal compilation © 2010 ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21143539     DOI: 10.1111/j.1365-3164.2010.00938.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  7 in total

Review 1.  Translational Animal Models of Atopic Dermatitis for Preclinical Studies.

Authors:  Britta C Martel; Paola Lovato; Wolfgang Bäumer; Thierry Olivry
Journal:  Yale J Biol Med       Date:  2017-09-25

2.  Clinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis.

Authors:  Ji-young Jung; Eui-hwa Nam; Seol-hee Park; Seung-hee Han; Cheol-yong Hwang
Journal:  J Vet Sci       Date:  2013-06-21       Impact factor: 1.672

3.  Glucocorticosteroids and ciclosporin do not significantly impact canine cutaneous microbiota.

Authors:  Giovanni Widmer; Lluís Ferrer; Claude Favrot; Judy Paps; Kevin Huynh; Thierry Olivry
Journal:  BMC Vet Res       Date:  2018-02-23       Impact factor: 2.741

Review 4.  Atopic Dermatitis in Animals and People: An Update and Comparative Review.

Authors:  Rosanna Marsella; Anna De Benedetto
Journal:  Vet Sci       Date:  2017-07-26

5.  Investigation on the Effect of Dose, Frequency and Duration of Allergen Exposure on Development of Staphylococcal Infections in a Chronic Model of Canine Atopic Dermatitis.

Authors:  Rosanna Marsella
Journal:  Vet Sci       Date:  2021-12-28

6.  Canine Epidermal Keratinocytes (CPEK) Grown in Monolayer Are Not Representative of Normal Canine Keratinocytes for Permeability Studies: Pilot Studies.

Authors:  Rosanna Marsella; Rachel Wilkes; Kim Ahrens
Journal:  Vet Sci       Date:  2022-01-11

7.  IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.

Authors:  K Bauer; E Hadzijusufovic; S Cerny-Reiterer; G Hoermann; M Reifinger; A Pirker; P Valent; M Willmann
Journal:  Vet Comp Oncol       Date:  2016-08-09       Impact factor: 2.613

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.